VB

Venugopala Bandi Rao

Active Director Director DIN 07290550
DIN 07290550 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Venugopala Bandi Rao

Data last updated:

Venugopala Bandi Rao is a Director at Stereokem Private Limited (since 2015). The company operates in Pharma. Stereokem Private Limited reported revenue of ₹13.93 Cr (FY 2024).

DIN 07290550
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2015
Oldest Company Age 17 yrs
Largest company Stereokem Private Limited · ₹13.93 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stereokem Private Limited U24232TG2009PTC064427
Director30 Sep 20152009₹13.93 Cr (FY 2024)Active

Board colleagues of Venugopala Bandi Rao

Directorship timeline

Open interactive timeline →
Stereokem Private Limited
Premium access

Shareholding and investment profile for Venugopala Bandi Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venugopala Bandi Rao

Venugopala Bandi Rao currently holds 1 directorship: Stereokem Private Limited (Director, since 30 Sep 2015, revenue ₹13.93 Cr (FY 2024)).

Venugopala Bandi Rao was first appointed on 30 Sep 2015 as Director at Stereokem Private Limited.

The current boards of Venugopala Bandi Rao's companies include Thaduri Srivani (Stereokem Private Limited), Venkateshwar Thaduri Kumar (Stereokem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available